Sunil Healthcare logo

Sunil Healthcare financials and balance sheet

NSE: SUNLOCBSE: 537253Pharmaceuticals & BiotechnologySmall Cap

Last close ₹69.00up ₹4.90 (7.64%)BSE ₹70.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹64.10.

52-week range of BSE trades to 23 Oct 2026
₹56.35Low, 7 Apr 2026₹82.31High, 1 Sep 2026
Market cap
₹71 Cr3,191st largest listed
P/E
19.9
P/B
1.0
Dividend yield
Nonein the last 12 months
ROE
5.2%
ROCE
4.9%
Debt to equity
0.80
Volume, NSE
24658.9% delivered

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Sunil Healthcare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Back to profit in the year to Mar 2026, ₹4.01 CrA loss in 5 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 3.2% of operating profit in the first full year.

The years either side of a change of basis do not compare. From the year to Mar 2018, GST replaced excise duty on 1 Jul 2017, and revenue before that day includes the duty. From the year to Mar 2020, the company reports a discontinued business.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue88
  2. Materials and goods−33
  3. Employee costs−13
  4. Other expenses−29
  5. Operating profit13
  6. Depreciation−6.4
  7. Other income+2.2
  8. One-off items−0.1
  9. Finance costs−6.2
  10. Profit before tax2.2
  11. Tax+1.8
  12. Net profit4.0

What the company owns

  • Plant, investments and other assets₹98 Cr
  • Receivables₹45 Cr
  • Inventory₹19 Cr
  • Cash and bank₹2 Cr

What pays for it: net worth and liabilities

  • Net worth₹70 Cr
  • Borrowings₹56 Cr
  • Other liabilities₹23 Cr
  • Owed to suppliers₹16 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Sunil Healthcare quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Filed 4 JulMar 2021Filed 17 JunMar 2022Filed 3 JunMar 2023Filed 29 MayMar 2024Filed 31 JulMar 2025Filed 16 JunMar 2026Filed 29 May
Revenue from operations10892817090119110908388
93––758510294867375
Materials and goods bought51282829434847463733
Employee costs–––13121415131213
Other expenses–––33303932272529
Operating profit before depreciation16––−55171641013
Operating margin14.4%––−6.6%5.9%14.6%14.6%4.5%12.3%14.5%
Materials, % of revenue–––40.8%47.3%40.7%42.7%51.4%44.0%37.4%
Employee costs, % of revenue–––18.6%13.6%11.9%13.4%14.3%14.1%14.7%
Other expenses, % of revenue–––47.2%33.2%32.8%29.3%29.7%29.6%33.4%
Depreciation and amortisation4––6667666
Operating profit after depreciation11––−11−1119−246
Other income22115624512
Finance costs4577534666
Profit before one-off items and tax96−1−3−199−3−12
One-off items0000000000
Profit before tax96−1−3−199−3−12
320−1033−10−2
Profit from discontinued businesses–––−3––––––
Net profit64−1−5−167−2−14
Other comprehensive income–––300−1140−1
Total comprehensive income–––−2−16612−13
Net margin5.1%4.9%−0.9%–−0.7%5.4%6.0%−2.0%−1.7%4.6%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2017 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2018 and Mar 2019: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given. Net margin is left blank for the year to Mar 2020: the profit includes the result of a business the company has discontinued, which the revenue does not, so the two make no margin.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2020Filed 4 JulMar 2021Filed 17 JunMar 2022Filed 3 JunMar 2023Filed 29 MayMar 2024Filed 31 JulMar 2025Filed 16 JunMar 2026Filed 29 May
45445056686770
Share capital10101010101010
Reserves34334046585759
44373435666956
66544045576366
19232019333229
Total assets130121110121158162165
71727573969791
59493548626574
Net debt39283131636653
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017, Mar 2018 and Mar 2019, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 17 JunMar 2022Filed 3 JunMar 2023Filed 29 MayMar 2024Filed 31 JulMar 2025Filed 16 JunMar 2026Filed 29 May
24.422.57.5−15.711.522.2
24.223.78.8−15.011.522.3
13.95.2−10.4−23.2−0.17.5
Receivables3.92.0−9.9−14.3−0.1−7.7
Inventories11.12.7−2.5−0.4−3.6−1.1
Payables1.6−3.54.5−7.93.614.3
Other working capital−2.74.0−2.4−0.50.01.9
Tax paid0.2−1.2−1.4−0.80.0−0.2
Capital spending6.89.04.210.19.43.6
Free cash flow17.613.53.3−25.92.118.6
−11.5−4.2−3.4−9.8−7.7−2.8
−13.7−18.6−3.725.0−3.9−19.3
Dividends paid0.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash−0.8−0.30.3−0.50.00.0
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Filed 4 JulMar 2021Filed 17 JunMar 2022Filed 3 JunMar 2023Filed 29 MayMar 2024Filed 31 JulMar 2025Filed 16 JunMar 2026Filed 29 May
Earnings per share₹5.38₹4.38−₹0.67––₹6.26₹6.52−₹1.74−₹1.38₹3.91
Diluted earnings per share₹5.38₹4.38−₹0.67––₹6.26₹6.52−₹1.74−₹1.38₹3.91
Book value per share–––₹43.49₹42.63₹48.71₹54.61₹66.52₹65.40₹67.87
Shareholder yield––––0.0%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)97.269.835.115.223.473.058.563.267.263.5
Earnings per share is left blank for the year to Mar 2020: the earnings per share stated does not match any profit the filing states over the shares in issue, and the share count barely moved during the period. Earnings per share is left blank for the year to Mar 2021: the earnings per share stated has the opposite sign to the profit stated beside it, so it is not shown.

Ratios

Consolidated, years to March.Sunil Healthcare PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Mar 2020Filed 4 JulMar 2021Filed 17 JunMar 2022Filed 3 JunMar 2023Filed 29 MayMar 2024Filed 31 JulMar 2025Filed 16 JunMar 2026Filed 29 May
Revenue growth––––28.9%32.0%−7.3%−18.4%−7.5%5.2%
Operating profit growth–––––226.5%−7.0%−74.7%151.0%24.4%
Net profit growth–−18.5%––––4.1%–––
Earnings per share growth–−18.6%––––4.2%–––
–––−11.1%−1.4%13.7%12.6%−2.9%−2.1%5.9%
––––9.7 pts15.2 pts−1.1 pts−15.5 pts0.8 pts8.0 pts
From the net margin–––––12.5 pts1.7 pts−16.7 pts0.4 pts7.7 pts
From asset turnover–––––4.8 pts−1.1 pts1.3 pts0.5 pts0.2 pts
From borrowing–––––−2.1 pts−1.6 pts−0.1 pts−0.1 pts0.0 pts
Return on capital employed–––−12.1%−1.0%13.2%10.0%−1.5%2.9%5.0%
Cash conversion–––––350.6%111.8%––553.0%
Interest cover2.7––––3.22.2–0.61.0
Debt to equity–––0.990.840.690.630.971.020.80
Receivable days–––123955894164182188
Inventory days–––31711783105111176209
Payable days–––288172651144889178
Cash conversion cycle, days–––152407685227269219
Working capital days–––105334682192213189
Asset turnover–––0.540.721.040.960.650.520.54
Assets per rupee of net worth–––2.922.842.462.182.252.372.39
Sales per rupee of plant–––1.261.652.162.021.660.891.02
Capital spending to depreciation––––1.121.430.601.661.480.56
Plant being built, % of plant in use–––0.0%0.0%3.2%0.0%10.4%0.1%2.1%
Revenue growth is left blank for the years to Mar 2018 and Mar 2019: between the two periods excise duty was taken out of revenue when GST replaced it, so the two are on different bases and the change is not worked out. Interest cover is left blank for the years to Mar 2020, Mar 2021 and Mar 2024: operating profit after depreciation is a loss, and a loss covers no interest bill. Revenue growth is left blank for the year to Mar 2020: between the two periods the company began reporting a business as discontinued, so the two are on different bases and the change is not worked out. From the net margin, from asset turnover and from borrowing are left blank for the year to Mar 2021: the profit of this year or the year before includes a business the company has discontinued while its revenue does not, so the change in return on equity is not split into margin, turnover and borrowing. No balance sheet is on record for the years to Mar 2017, Mar 2018 and Mar 2019, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
2.5%
Cash from operations against operating profit
173.6%
Measure10 years5 years3 years
Revenue growth, yearly rate–−0.6%−7.4%
Profit growth, yearly rate––−15.7%
Return on equity, average–5.4%0.3%
Return on capital employed, average–5.9%2.1%
Operating margin, average–12.1%10.5%
Net margin, average2.3%2.5%0.3%
Asset turnover, average–0.740.57
Cash conversion cycle, days, average–175238
Interest cover, average–1.80.8
Debt to equity, average–0.820.93

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations47.917.922.2
Cash from investing−28.0−20.3−2.8
Cash from financing−20.41.9−19.3
Capital spending36.423.13.6
Dividends paid0.00.00.0
Shares bought back0.00.00.0
Shares issued for cash0.00.00.0
Borrowings raised34.427.50.6
Borrowings repaid53.232.113.9

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9–––––88269
Altman Z-scorePublished threshold 1.81–––1.051.402.662.391.611.561.66
Beneish M-scorePublished threshold −1.78––––−3.20−3.15−2.03−1.18−3.21−2.70
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––−10.84−10.302.2716.99−3.27−9.37
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––4.361.260.9322.39
Receivables growth less revenue growthOur threshold 0 percentage points––––−29.48−51.3557.6661.2310.113.22
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––––−94.18−32.9425.625.0746.4916.81
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––––−2.84−1.400.682.30−1.805.61
Assets under construction, years of additionsOur threshold 2 years of additions––––0.000.260.001.000.00–
Effective tax ratePublished threshold 17.16 per cent35.9828.79–––30.7029.54––−79.64
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––17.8415.01––−86.83
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
5 Oct 2026CARE Ratings Limited (opens in a new tab)Fund-based - LT-Cash CreditLong-term scaleCARE BB; ISSUER NOT COOPERATING*Review, DowngradeRating moved to ISSUER NOT COOPERATING categoryStable25
5 Oct 2026CARE Ratings Limited (opens in a new tab)Fund-based - LT-Term LoanLong-term scaleCARE BB; ISSUER NOT COOPERATING*Review, DowngradeRating moved to ISSUER NOT COOPERATING categoryStable13.85
5 Oct 2026CARE Ratings Limited (opens in a new tab)Non-fund-based - ST-BG/LCShort-term scaleCARE A4; ISSUER NOT COOPERATING*Review, DowngradeRating moved to ISSUER NOT COOPERATING category18.25
5 Oct 2026CARE Ratings Limited (opens in a new tab)Non-fund-based - ST-Forward ContractShort-term scaleCARE A4; ISSUER NOT COOPERATING*Review, DowngradeRating moved to ISSUER NOT COOPERATING category0.60
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.